PHASE I STUDY OF COMBINED CHEMOTHERAPY CONSISTING OF 2-CHLORODEOXYADENOSINE

Project: Research project

Project Details

Description

To assess hematologic and nonhematologic toxicity of chlorambucil (CLB) when combined with escalating doses of 2-chlorodeoxyadenosine (2-CDA) in patients with chronic lymphoid leukemias and low-grade lymphomas. To obtain pharmacokinetic data during infusion of 2-CDA combined with CLB and to monitor tumor response.
StatusFinished
Effective start/end date10/1/929/30/94

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.